Health at a Glance 2015
OECD Indicators
![image of Health at a Glance 2015 image of Health at a Glance 2015](https://assets.oecdcode.org/covers/100/g2g59f78.jpg)
This new edition of Health at a Glance presents the most recent comparable data on the performance of health systems in OECD countries. Where possible, it also reports data for partner countries (Brazil, China, Colombia, Costa Rica, India, Indonesia, Latvia, Lithuania, Russian Federation and South Africa). Compared with the previous edition, this new edition includes a new set of dashboards of health indicators to summarise in a clear and user-friendly way the relative strengths and weaknesses of OECD countries on different key indicators of health and health system performance, and also a special focus on the pharmaceutical sector. This edition also contains new indicators on health workforce migration and on the quality of health care.
- Click to access:
-
Click to download PDF - 4.41MBPDF
-
Click to download EPUB - 16.52MBePUB
Pharmaceutical consumption
In general, pharmaceutical consumption continues to increase, partly driven by a growing demand for drugs to treat ageing-related and chronic diseases and by changes in clinical practice. This section examines consumption of four categories of pharmaceuticals: antihypertensive, cholesterol-lowering, antidiabetic and antidepressant drugs. Consumption is measured in defined daily doses (DDD) (see the box on Definition and comparability).
Also available in: French
- Click to access:
-
Click to download PDF - 268.75KBPDF